Management of immune checkpoint inhibitors-derived dermatologic adverse events - EADV | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EADV
2021
·
Europe
·
Dermatology
Management of immune checkpoint inhibitors-derived dermatologic adverse events
Document
Analyser ce document